To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Epilepsi och stroke – nya… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Epilepsi och stroke – nya rön om diagnos, behandling och prognos.

Journal article
Authors Johan Zelano
Published in Läkartidningen
Volume 114
ISSN 0023-7205
Publication year 2017
Published at
Language sv
Keywords Anticonvulsants, therapeutic use, Drug Prescriptions, statistics & numerical data, Epilepsy, diagnosis, drug therapy, etiology, mortality, Humans, Prognosis, Risk Factors, Stroke, complications, mortality
Subject categories Neurology


Poststroke epilepsy: update on diagnosis, treatment and prognosis  Recent advances in our understanding of poststroke epilepsy have implications for clinical practice. Epidemiological studies indicate cumulative risks of 5-12%. The main risk factors are large lesions, hemorrhage, cortical lesions, and early seizures. Clinical trials have shown levetiracetam and lamotrigine to be appropriate first-line treatment options, with favorable tolerability and lack of significant interactions with secondary stroke prophylaxis. Seizure freedom is often achieved in prospective trials, but data from routine health care are less impressive. Unfortunately, observational studies suggest that poststroke epilepsy is associated with poor survival. This partly reflects the greater risk of epilepsy seen in severe stroke, but even the influence of epilepsy or antiepileptic drugs on stroke prognosis needs further study. The most current research areas include prevention of seizures and epileptogenesis and the impact of late-onset epilepsy on vascular risk.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?